The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice

Yuri Kim, Dillon Phan, Eva Van Rooij, Da Zhi Wang, John McAnally, Xiaoxia Qi, James A Richardson, Joseph A Hill, Rhonda S Bassel-Duby, Eric N Olson

Research output: Contribution to journalArticlepeer-review

187 Scopus citations


The adult heart responds to excessive neurohumoral signaling and workload by a pathological growth response characterized by hypertrophy of cardiomyocytes and activation of a fetal program of cardiac gene expression. These responses culminate in diminished pump function, ventricular dilatation, wall thinning, and fibrosis, and can result in sudden death. Myocyte enhancer factor-2 (MEF2) transcription factors serve as targets of the signaling pathways that drive pathological cardiac remodeling, but the requirement for MEF2 factors in the progression of heart disease in vivo has not been determined. MEF2A and MEF2D are the primary MEF2 factors expressed in the adult heart. To specifically determine the role of MEF2D in pathological cardiac remodeling, we generated mice with a conditional MEF2D allele. MEF2D-null mice were viable, but were resistant to cardiac hypertrophy, fetal gene activation, and fibrosis in response to pressure overload and β-chronic adrenergic stimulation. Furthermore, we show in a transgenic mouse model that forced overexpression of MEF2D was sufficient to drive the fetal gene program and pathological remodeling of the heart. These results reveal a unique and important function for MEF2D in stress-dependent cardiac growth and reprogramming of gene expression in the adult heart.

Original languageEnglish (US)
Pages (from-to)124-132
Number of pages9
JournalJournal of Clinical Investigation
Issue number1
StatePublished - Jan 2 2008

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice'. Together they form a unique fingerprint.

Cite this